Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure
2008; Oxford University Press; Volume: 80; Issue: 3 Linguagem: Inglês
10.1093/cvr/cvn215
ISSN1755-3245
AutoresPasquale Gallo, Michael V.G. Latronico, Paolo Gallo, Séréna Grimaldi, Francesco Borgia, Matilde Todaro, Philip Jones, Paola Gallinari, Raffaele De Francesco, Gennaro Ciliberto, Christian Steinkühler, Giovanni Esposito, Gianluigi Condorelli,
Tópico(s)Protein Degradation and Inhibitors
ResumoAimsRecent studies have demonstrated the importance of chromatin remodelling via histone acetylation/deacetylation for the control of cardiac gene expression. Specific histone deacetylases (HDACs) can, in fact, play a positive or negative role in determining cardiac myocyte (CM) size. Here, we report on the effect on hypertrophy development of three inhibitors (HDACi) of class I HDACs.
Referência(s)